Skip to content
Integer Holdings logo

Integer Holdings

ITGR

Integer Holdings Corporation is a leading global medical device contract development and manufacturing organization (CDMO) specializing in the design and production of complex medical technologies.

Market cap
$3.12B-26.5%
Revenue$1.9B+6.3%
Net income$141.8M+84.4%
Free cash flow$99.8M-10.7%
EPS (diluted)$4.00+89.6%
Trailing twelve months · change vs. prior year

Earnings

Next report

Aug 6, 2026 (In 3 weeks)
Revenue estimate$450.5M
EPS estimate$1.38

Financials

Q1 2026

Income statement

See full
Revenue$439.6M+0.5%
Gross profit$109.6M-8.9%
Operating income$31.9M-35.7%
Net income$16.5M+173%
EPS (diluted)$0.48+173%

Balance sheet

See full
Cash & equivalents$8.1M-74.4%
Total debt$1.4B+2.0%
Total equity$1.7B+5.6%
Total assets$3.4B+3.5%

Cash flow

See full
Operating cash flow$24.7M-21.0%
CapEx$24.0M-5.0%
Free cash flow$737.0K-87.8%

Valuation & ratios

Valuation

See full
Market cap$3.12B-26.5%
Enterprise value$4.5B-16.5%
P/E22×-27.4×
P/S1.7×-0.6×

Profitability

See full
Gross margin26.4%-0.6pp
Operating margin11%-1.6pp
Net margin7.6%+3.2pp
FCF margin5.4%-1.0pp

Returns & leverage

See full
Return on equity8.6%+3.7pp
Debt / equity0.8×0.0×
Current ratio3.8×+0.4×

Segments

By product

See full
Cardio & Vascular$261.7M+1.1%
Cardiac Rhythm Management & Neuromodulation$168.3M+4.9%
Other Markets$9.6M-47.3%

Competitors

Profile

Integer Holdings Corporation is a leading global medical device contract development and manufacturing organization (CDMO) specializing in the design and production of complex medical technologies. The company serves as a strategic partner to major original equipment manufacturers, providing engineering expertise and manufacturing scale for high-growth medtech markets including cardiovascular and neuromodulation therapies.

Competitive position

Integer is one of the world's largest medical device CDMOs with a pure-play focus on high-growth medtech markets and differentiated coating and engineering capabilities.

GeographiesGlobal, North America, Europe, Asia
Customer segmentsMedical Device OEMs, Multi-national Healthcare Corporations
Business modelB2B, Contract Development and Manufacturing (CDMO), Outsourced Manufacturing
SuppliersRaw material suppliers (metals, polymers), Specialized chemical providers, Electronic component manufacturers
CustomersMulti-national medical device OEMs, Specialized medical technology startups, Healthcare systems (indirectly via OEMs)
Listed2000
Employees10.5K
CEOPayman Khales
FilingsSEC EDGAR

Questions, answered.

What is Integer Holdings's market cap?
Integer Holdings (ITGR) has a market capitalization of $3.1B and trades on NYSE.
What is Integer Holdings's revenue and profitability?
Integer Holdings generated $1.9B in trailing twelve-month revenue with net income of $141.8M, representing a net margin of 7.6%. Gross margin stands at 26.4%, with free cash flow of $99.8M. These figures are based on the Q1 2026 filing.
Who are Integer Holdings's competitors?
Integer Holdings's key competitors include Teleflex, TE Connectivity, Merit Medical Systems Inc, and others. These companies compete in similar markets and product categories.
What subsidiaries does Integer Holdings have?
Integer Holdings's subsidiaries include Greatbatch Medical, Lake Region Medical, Biocoat Incorporated, and others.
Where is Integer Holdings headquartered?
Integer Holdings is headquartered in United States of America and employs approximately 10,500 people. It has been publicly traded since 2000.